Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CSPG4P1Y - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RUFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MSH4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYB5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC37-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARCH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100653137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UST-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECSCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FTCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARRDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP57L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on